New evidence reveals how COVID-19 may trigger fatal clotting through hidden vascular damage, reshaping global medical ...

Severe bleeding after trauma can rapidly become life-threatening. In a new doctoral thesis from Karolinska Institutet, Marcus ...

CRISPR Therapeutics (Nasdaq: CRSP) today reported financial results for the first quarter ended March 31, 2026. “The first ...

Immunothrombosis is increasingly recognized as a key pathophysiological process in emerging tropical diseases, linking innate immune responses, endothelial ...

Cadrenal is now planning a randomized, placebo-controlled study alongside standard anticoagulants. ・The company's Phase 2 data showed over a 25% reduction in clotting, though the trial missed its ...

Patterns of molecular activity in the blood may hold clues not only to how fit someone is, but also to the biological ...

Bayer has reaffirmed its growth ambitions towards 2030, underpinned by a strengthened pharmaceutical portfolio, advanced ...

When a newborn requires surgery, the question of how to manage bleeding becomes more complicated than it is for adults or older children. Infant blood clots differently. The fibrin network that forms ...

Scientists from Kumamoto University in Japan have created a new blood test that can catch the earliest signs of blood clotting. This is a big step forward for treating heart disease and other ...

While traditional thrombolytics focus on fibrin degradation, this novel therapy targets and inhibits von Willebrand Factor (vWF), a key protein in platelet adhesion. By targeting an alternative but ...

Using a high-sensitivity blood test (SMAT) that measures initial thrombin generation (ITG)—the very first step of blood clot formation—the researchers analyzed blood samples from 771 patients with ...